ArticleFrontiers in urology2025
Robot-assisted conversion of ureterocutaneous stoma to ileal conduit: a novel option for patients with post-cystectomy cutaneous diversion complicated by ureteral stricture and recurrent infections.
Article in Frontiers in urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radical cystectomy accompanied by urinary diversion remains the standard surgical intervention for individuals diagnosed with muscle-invasive bladder cancer. Notably, around 30% of these patients opt for a ureterocutaneous stoma. However, this technique is frequently associated with complications such as anastomotic stenosis, obstruction, and infection, which can lead to the deterioration of renal function and significantly impair the patient's quality of life. Consequently, this study investigates the safety of robot-assisted laparoscopic conversion from a ureterocutaneous stoma to an ileal conduit stoma, thereby offering a novel surgical alternative for patients undergoing total cystectomy with ureterocutaneous stoma. Methods: A retrospective analysis was carried out on two patients who underwent total cystectomy and ureterocutaneous stoma and were admitted to our hospital in January 2025. We performed robot-assisted laparoscopic conversion of the ureterocutaneous stoma to an ileal conduit for these patients and subsequently evaluated the clinical benefits and surgical safety associated with the procedure. Result: Both patients successfully underwent surgery, with operation durations of 293 minutes and 281 minutes, respectively. Intraoperative blood loss was recorded at 100 ml and 50 ml, respectively. Abdominal drainage tubes were removed five days postoperatively, and both patients were discharged seven days following the procedure. No surgery-related complications were observed during the perioperative period. Ureteral stents were removed two months post-surgery. Post-extubation CT scans indicated a resolution of the initial mild hydronephrosis in the kidneys. Renal function assessments, including creatinine levels and glomerular filtration rate, demonstrated improvement compared to preoperative values. Additionally, patients reported lower pain scores and higher quality of life scores postoperatively compared to preoperative assessments. Conclusion: Robot-assisted laparoscopic ureterocutaneostomy to ileal channel surgery is both feasible and safe, offering potential improvements in renal function and quality of life for patients. Additionally, it presents an alternative surgical option for those requiring ureterocutaneostomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.